Press Release: NeurAxon : Knight Therapeutics Inc. and NeurAxon Inc. Form Partnership for the Commercialization of NeurAxon's Innovative Products

MONTREAL, QUEBEC--(Marketwired - Jan. 1, 2015) - Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, today announced that it has entered into a strategic partnership with NeurAxon Inc. ("NeurAxon") for the commercialization of NeurAxon's innovative products in various stages of development ("Pharmaceuticals") in Canada, Israel, South Africa and Russia ("Territory").